期刊
PATIENT PREFERENCE AND ADHERENCE
卷 15, 期 -, 页码 1963-1970出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/PPA.S330689
关键词
COVID-19; vaccines; side effects; symptoms; Pfizer-BioNTech; Oxford-AstraZeneca
资金
- Deanship of Scientific Research at King Khalid University [GRP/290/42]
The study found that the most common side effects reported by participants in the Aseer region of Saudi Arabia after receiving the COVID-19 vaccines were fever, myalgia, malaise, muscle and joint pain, and headache. Symptoms were more common in males than in females. Despite a certain infection rate, the side effects of COVID-19 vaccines were consistent with the manufacturers' data.
Background: The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown promising safety and acceptability. However, COVID-19 vaccine side effects play an essential role in public vaccine confidence. We aimed to study the side effects of these COVID-19 vaccines. Methods: A randomized, cross-sectional descriptive study was conducted between March and May of 2021. In total, 330 participants among the King Khalid University community in the Aseer region of the Kingdom of Saudi Arabia reported their side effects following the COVID-19 vaccine. A questionnaire was designed and validated to collect the participants' demographic data and COVID-19-related symptoms after COVID-19 vaccine injection. Results: Symptoms associated with COVID-19 were reported by 226 participants (68.5%). The most common side effects reported by the participants were fever (n = 136, 41.2%), fatigue (n = 119, 36.1%), headache (n = 86, 24.2%), malaise (n = 121, 36.7%), myalgia (n = 121, 36.7%), and muscle and joint pain (n = 76, 23%). Of the participants, 5.1% became infected with COVID-19 after vaccination. Symptoms were significantly more common in males than in females (p = 0.006). Conclusion: The incidence of COVID-19 vaccination side effects in the Aseer region, Kingdom of Saudi Arabia, was consistent with the manufacturers' data. The most common post-vaccination symptoms reported by the participants were fever, myalgia, malaise, fati-gue, muscle and joint pain, and headache. The results of this study showed significant variation in adverse events between Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines. Healthcare providers and recipients of vaccines can be more confident about the safety of Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据